Table 5.
Multivariate logistic regression analyses showing associations of NAFLD with FT3 among type 2 diabetic patients.
| Model | FT3 | |||
|---|---|---|---|---|
| B | P | OR | 95% CI | |
| Model 1 | 0.253 | <0.05 | 1.288 | 1.062-1.562 |
| Model 2 | 0.251 | <0.05 | 1.286 | 1.006-1.644 |
| Model 3 | 0.263 | <0.05 | 1.301 | 1.028-1.645 |
| Model 4 | 0.313 | <0.05 | 1.367 | 1.068-1.751 |
Model 1 (adjusted for age, gender, T2DM duration, BMI, SBP, DBP, smoking history, TSH, and FT4), model 2 (adding FCP, 2h-CP, AbG, FbG, 2hbG, HOMA-IR, and HbA1c on the basis of model 1), model 3 (adding urea, CR, UA, and GFR to model 2), and model 4 (adding ALT, AST, GGT, TC, TG, HDL-C, and LDL-C to model 3). P < 0.05 was considered statistically significant.